Cargando…
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation
BACKGROUND & AIMS: Studies have shown decreased response to coronavirus disease 2019 (COVID-19) vaccinations in some populations. In addition, it is possible that vaccine-triggered immune activation could trigger immune dysregulation and thus exacerbate inflammatory bowel diseases (IBD). In this...
Autores principales: | Lev-Tzion, Raffi, Focht, Gili, Lujan, Rona, Mendelovici, Adi, Friss, Chagit, Greenfeld, Shira, Kariv, Revital, Ben-Tov, Amir, Matz, Eran, Nevo, Daniel, Barak-Corren, Yuval, Dotan, Iris, Turner, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697416/ https://www.ncbi.nlm.nih.gov/pubmed/34954338 http://dx.doi.org/10.1016/j.cgh.2021.12.026 |
Ejemplares similares
-
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN
por: Gorelik, Yuri, et al.
Publicado: (2022) -
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children
por: Atia, Ohad, et al.
Publicado: (2020) -
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix
por: Atia, Ohad, et al.
Publicado: (2022) -
BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign
por: Ben-Tov, Amir, et al.
Publicado: (2021) -
The risk of serious bacterial infections among young ex-premature infants with fever
por: Barak-Corren, Yuval, et al.
Publicado: (2022)